James H Lan

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Kidney Transplantation

Mesenchymal Stem Cells

Clinical Evaluation

Top Venues

Journal of the American Society of Nephrology : JASN

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

This page only lists publications with an associated author ORCID identifier.

Publications

James H Lan
Assessment of Novel Therapeutics to Improve Access to Transplantation for Highly Sensitized Patients in a Shifting Clinical Landscape. Journal of the American Society of Nephrology : JASN (2024)
James H Lan
Assessment of Novel Therapeutics to Improve Access to Transplantation for Highly Sensitized Patients in a Shifting Clinical Landscape. Journal of the American Society of Nephrology : JASN 35 (3) (2024)
James H Lan
Assessment of Novel Therapeutics to Improve Access to Transplantation for Highly Sensitized Patients in a Shifting Clinical Landscape. Journal of the American Society of Nephrology : JASN 35 (3) (2024)
James H Lan
Assessment of Novel Therapeutics to Improve Access to Transplantation for Highly Sensitized Patients in a Shifting Clinical Landscape. Journal of the American Society of Nephrology : JASN 35 (3) (2024)
James H Lan
Assessment of Novel Therapeutics to Improve Access to Transplantation for Highly Sensitized Patients in a Shifting Clinical Landscape. Journal of the American Society of Nephrology : JASN 35 (3) (2024)
James H Lan
Assessment of Novel Therapeutics to Improve Access to Transplantation for Highly Sensitized Patients in a Shifting Clinical Landscape. Journal of the American Society of Nephrology : JASN 35 (3) (2024)
James H Lan
Assessment of Novel Therapeutics to Improve Access to Transplantation for Highly Sensitized Patients in a Shifting Clinical Landscape. Journal of the American Society of Nephrology : JASN 35 (3) (2024)
Loren Gragert, Matthew J Kadatz, James Alcorn, Darren E Stewart, Doris Chang, Jagbir Gill, Robert Liwski, Howard M Gebel, John S Gill, James H Lan
ABO-adjusted calculated panel reactive antibody (cPRA): A unified metric for immunologic compatibility in kidney transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 22 (12) (2022)